CD28-IN-3
CD28-IN-3 is a CD28 inhibitor with an IC50 of 7.80 μM and a Kd of 52.45 μM. CD28-IN-3 selectively blocks the CD28-B7 interaction, thereby inhibiting CD28-mediated costimulation. CD28-IN-3 suppresses the production of proinflammatory cytokines IFN-γ, IL-2 and TNF-α. CD28-IN-3 can be used in the research of checkpoint-resistant cancers.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 850550-70-8
- 分子式: C17H24N4OS2
- 分子量:364.53
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
CD28-IN-3 (Compound 22VS) (0-100 μM; 2 h) inhibits the interactions of membrane-bound CD28-CD80 and CD28-CD86 in CHO-K1 cells, with corresponding submicromolar IC50 values of 1.48 μM and 1.39 μM, respectively[1].
CD28-IN-3 (10-300 μM; 24 h) shows no cytotoxicity against human Jurkat T lymphocytes even at concentrations up to 300 μM following a 24 h incubation[1].
CD28-IN-3 (0-200 μM; 5 h) inhibits CD28-mediated T cell costimulation in the Jurkat-Raji co-culture system, with an IC50 of 6.96 μM[1].
CD28-IN-3 (10-50 μM; 48 h) inhibits the release of CD28-dependent proinflammatory cytokines (IFN-γ, IL-2, TNF-α) in a dose-dependent manner in 3D A549 tumor-PBMC co-culture systems and human PBMC-mucosa co-culture systems[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human Jurkat T lymphocytes
-
Concentration:10, 30, 100 and 300 μM
-
Incubation Time:24 h (37°C)
-
Result:Maintained cell viability above 85% at all tested concentrations, showing no measurable cytotoxicity.
化学情報
-
CAS 番号 850550-70-8
-
分子量 364.53
-
分子式 C17H24N4OS2
-
SMILES
CCC(NC(CSC1=NN=C(S1)NC2=CC=C(C=C2)C(C)C)=O)C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)